i've thought about the 31 day sell but i would never forgive myself if they announce a partner and got a run. That would be the ultimate kick in the berries! Yes...that 11B was a purchase. My thought with technosphere is license to existing compounds. Hopefully that would stem the 10 year issue (which you are right about). I do think inhaled drugs will be seen as less taboo in the future one Afrezza and Mapp's drug are approved. Mapp will come first... inhalable migraine meds is such a no brainer and their last CRL was very light. I'm not sure it is a great investment though given current valuation.
